National Kidney Foundation and Labcorp Data Show Millions Aren't Tested for Kidney Disease

July 29, 2021

Labcorp announces 2021 second quarter results

Company Raises Full Year Guidance Revenue: Q2 of $3.8 billion , versus $2.8 billion last year Diluted EPS: Q2 of $4.76 , versus $2.37 last year Adjusted EPS: Q2 of $6.13 , versus $2.57 last year Free Cash Flow: Q2 of $390 million , versus $272 million last year Acquired remaining ownership interest

Labcorp to Offer First and Only FDA-Cleared Test for Monitoring Residual Blood Cancer Cells During and After Treatment

July 8, 2021

Medical Home Network, Labcorp collaboration harnesses data analytics to provide more comprehensive patient health picture

CHICAGO, July 8, 2021 - Medical Home Network (MHN) today announced a collaboration with Labcorp, a leading global life sciences company, to securely integrate lab results into patient records. The agreement will help MHN members within the Accountable Care Organization (MHN ACO) achieve better care and health at a lower cost for the more than 160,000 Medicaid safety net patients served by the MHN ACO.

Labcorp Selected as a UnitedHealthcare Preferred Lab Network Provider for the Third Year in a Row

Labcorp Launches Companion Diagnostic For Amgen's Newly-Approved Lung Cancer Therapy